A groundbreaking therapy aimed at reversing cellular aging has been administered to the first human participant in a world-first clinical trial, marking a significant milestone in longevity research.
A groundbreaking therapy aimed at reversing cellular aging has been administered to the first human participant in a world-first clinical trial, marking a significant milestone in longevity research.